Communicable and Infectious Diseases

 

 

 

Student’s Name

University

Course

Professor

Date

 

Communicable and Infectious Diseases

Sexually Transmitted Diseases and HIV and AIDS

In a unified globe where germs are no frontiers, the looming threat of communicable and infectious menaces involves our unhesitating attention and combined action. Communicable and infectious afflictions are infections caused by microorganisms or pathogens transmitted from one individual to another, either directly or indirectly. These disorders are a significant affair for public health because they can spread swiftly within communities and populations. Typical examples of communicable and infectious afflictions are influenza, TB, HIV/AIDS, Corona, and malaria (Long-Marin & Smith, 2021). They can be rooted by bacteria, viruses, parasites, or fungi and can be dispatched through numerous routes like respiratory droplets, adulterated food or water, sexual intercourse, and insect bites. Avoidance and control of these menaces frequently include measures like vaccination, proper hygiene practices, appropriate sanitation, using personal protective gear, and treating and identifying the infected individuals on time. Public health authorities play a critical role in observing and responding to outbreaks of communicable and infectious menaces, limiting their effects on individuals and communities. This paper will explore communicable and infectious disorders looking at their similarities in case of any reason as to why there is no typical STI, and present an overview of the medication prep, discussing the pros and cons of using the medication in the prevention of communicable and infectious disorders.

Comprehending Communicable and Infectious Afflictions: Definitions, Similarities, and Classification

Communicable afflictions and infectious disorders are connected terms describing distinct aspects of the same concept. A contractible disorder is an affliction that can be transferred directly and indirectly from one person to another. It indicates a pathogen’s ability to spread from an impacted person to a susceptible person (Stockmaier et al., 2021). On the other hand, infectious disorders are rooted in microorganisms like bacteria, viruses, fungi, and parasites, invading and increasing within a host organism, resulting in illness. Additionally, contagious disorders are rooted in infectious agents, but communicable afflictions aim at the transmission and spread of these infectious agents. There is a crucial overlap between communicable and infectious disorders. Numerous infectious disorders are communicable, highlighting that they can be transferred from individual to individual. For an instant, the common cold, influenza, TB, and COVID-19 are all communicable afflictions. These afflictions are rooted in pathogens that can be transferred through respiratory droplets, direct contact, and adulterated surfaces. Communicable disorders can also involve non-infectious causes like definite types of cancers or poisoning. Nevertheless, most communicable disorders involve infectious agents (Molefe et al., 2018). It is essential to understand that not all infectious disorders are communicable. Some infectious afflictions are rooted in pathogens that cannot be transferred among individuals, like tetanus, caused by the bacterium Clostridium tetani, obtained through deflating wounds. The codification of afflictions as communicable or infectious is situated on their mode of transfer and the conducive agent included. Both expressions indicate distinct aspects of the disorders, with communicable disorders highlighting the possibility for transfer and infectious afflictions aiming at the role of pathogens in rooting illness.

The Irregular STI Patient: Exploring the Atypical Qualities and the Intensified Risk of HIV Transfer

No, a typical sexually transmitted infection individual does not live as STIs can impact individuals of all genders, ages, sexual assimilation, and socioeconomic backgrounds. Sexually transmitted infections do not distinguish and can be acquired by anyone having unprotected sexual intercourse with a partner who is infected with the disorder. It is essential to understand that the risk of acquiring an STI is not absolutely resolute by an individual’s behavior or lifestyle modifications, including factors like access to healthcare, education, and societal basis. The existence of an STI greatly maximizes the risk of HIV transfer because of numerous reasons. To start with, most STIs lead to inflammation, ulcers, or open sores near the genital area, making it simple for HIV to enter the body in the course of sexual activities (Mwatelah et al., 2019). The existence of STIs can bargain the unity of mucous membranes and skin, offering an entry point for HIV. Secondly, definite STIs like syphilis, herpes, and chlamydia can intensify the amount of CD4 cells and immune system vivification in the genital tract. The immune response attracts immune cells, involving those mainly chosen by HIV, to the site of disorders. The intensified presence of CD4 cells in the genital area develops more target cells for HIV to damage, hence taking part in its transmission (Kissinger et al., 2022). Additionally, STIs and HIV have similar risk factors and forms of transfer. Having unprotected sexual intercourse, having numerous sexual partners, and taking part in high-risk behaviors maximize the likelihood of STI and HIV transfer, and accordingly, individuals diagnosed with STIs are likely to take part in activities that place them at a higher risk of HIV infection. Comprehensively, an STI highly maximizes the risk of HIV transmission because of factors like inflammation, compromised mucous membranes, intensified immune activation, higher viral loosing, and shared risk factors. It is essential to enhance understandable sexual health education, ingress to healthcare, and frequent STI testing to prevent and manage both STIs and HIV.

Reconnoitering Prep (Truvada) and Assessing the Pros and Cons of its Role in Preventing Communicable and Infectious Disorders

Prep, also termed Truvada, is a medication mainly used for pre-exposure prophylaxis to prevent HIV transmission in high-risk persons, and it entails two active ingredients, emtricitabine and tenofovir disoproxil fumarate, working together to hinder the replication of the virus. The professional of using prep for disorder prevention is its high effectualness in lessening the risk of HIV transfer when taken persistently, its convenience as a once-daily pill and its possibility to empower individuals to protect themselves from getting the virus (Owens et al., 2019). Nevertheless, there are also some cons to take into count. Prep is not a hundred percent effective, so other preventive measures must still be practiced, like using condoms. In addition, it needs strict adherence to the medication procedure for capital effectiveness, and long-term use may pose possible risks, like kidney and bone issues. It is essential to consult a healthcare professional to describe individual risk factors, profits, and possible side effects before using prep for disorder prevention.

Conclusion

Comprehending communicable and infectious disorders is essential for effective prevention and management. By assessing definitions, similarities, and classifications, one can gain insights into the logic of these disorders. In addition, reconnoitering the atypical characteristics and heightened HIV transmission risk between STI patients has shed light on specific individuals’ distinctive challenges. By assessing the role of pre-exposure prophylaxis, like Truvada, one can take into account both advantages and disadvantages of such preventive methods. As one progresses to expand their knowledge and refine their strategies, it is evident that an understandable perspective in combating communicable and infectious disorders. Individuals can strive toward a healthier and safer future through collective efforts.

 

References

Kissinger, P. J., Gaydos, C. A., Seña, A. C., Scott McClelland, R., Soper, D., Secor, W. E., … & Muzny, C. A. (2022). Diagnosis and management of Trichomonas vaginalis: Summary of evidence reviewed for the 2021 Centers for disease control and Prevention sexually transmitted infections treatment guidelines. Clinical Infectious Diseases, 74(Supplement_2), S152-S161. https://doi.org/10.1093/cid/ciac030

Long-Marin, S. C., & Smith, D. E. (2021). Infectious Disease Prevention and Control. Foundations for Population Health in Community/Public Health Nursing-E-Book, 194.

Molefe, P. F., Masamba, P., Oyinloye, B. E., Mbatha, L. S., Meyer, M., & Kappo, A. P. (2018). Molecular application of aptamers in the diagnosis and treatment of cancer and communicable diseases. Pharmaceuticals, 11(4), 93. https://doi.org/10.3390/ph11040093

Mwatelah, R., McKinnon, L. R., Baxter, C., Abdool Karim, Q., & Abdool Karim, S. S. (2019). Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk. Journal of the International AIDS Society, 22, e25346. https://doi.org/10.1002/jia2.25346

Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., … & US Preventive Services Task Force. (2019). Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement. Jama, 321(22), 2203-2213.

Stockmaier, S., Stroeymeyt, N., Shattuck, E. C., Hawley, D. M., Meyers, L. A., & Bolnick, D. I. (2021). Infectious diseases and social distancing in nature. Science, 371(6533), eabc8881.

If you are having challenges with writing your nursing essay either because of lack of time or not knowing where to start, you can order your paper here